Table 2.

RCTs evaluating the visual outcomes or adverse outcomes between antifungal medications

RCT	Intervention	Number	Outcome criteria	Outcome
Mahdy 201019	Topical Amphotericin B 0.05% + subconjunctival Fluconazole 0.2% vs Topical Amphotericin 0.05%	48	Number of perforations and visual outcome	Both therapies equivalent in both criteria
Prajna 201020	Topical Voriconazole 1% vs Topical Natamycin 5%	120	Visual acuity and number of perforations and corneal transplants	Visual acuity slightly superior in Voriconazole but not statistically significant. No difference in rate of complications
Arora 201021	Topical Voriconazole 1% vs Topical Natamycin 5%	30	Visual acuity	No significant difference